Stephen Shopbell, MD
Psychiatry · Neenah, WINPI 1326032335
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $15,160 of the $16,501 with a category attached, or 91.9%. AbbVie accounts for 97.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $10,264 and has fallen 98.8% since, to $126 in 2025. Among psychiatry clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $253.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$16K
- E.r. Squibb & Sons, L.L.C.$126
- Supernus Pharmaceuticals, Inc.$67
- Otsuka America Pharmaceutical, Inc.$57
- Lundbeck LLC$43
- Jazz Pharmaceuticals Inc.$29
- plus $172 from 8 others
What the payments were for
- Speaking & faculty fees$15,16092%
- Travel & lodging$4963%
- Food & beverage$8455%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $16,007 |
| E.r. Squibb & Sons, L.L.C. | 1 | $126 |
| Supernus Pharmaceuticals, Inc. | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Lundbeck LLC | 3 | $43 |
| Jazz Pharmaceuticals Inc. | 2 | $29 |
| Alkermes, Inc. | 2 | $29 |
| Shire North American Group Inc | 2 | $28 |
| Bausch Health US, LLC | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $25 |
| Johnson & Johnson | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Tris Pharma Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,501 in reported general payments places this provider in the 95th percentile of 543 psychiatry providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine | 11 | $190 |
| Trazodone Hcl | 11 | $88 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Neenah
- Scott WienerGreenfield$1.4M
- Joseph BergsRacine$346K
- Royle EenigenburgJuneau$344K
- Thomas IlicMilwaukee$324K
- Jay WinstonMilwaukee$238K
- Joseph BurgarinoMilwaukee$111K
- Sobia Kirmani MoeMadison$104K
- Jacob BehrensMilwaukee$94K
- Ned KalinMadison$48K
- Kenneth HerrmannMadison$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.